BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 31503372)

  • 1. Impact of new definitions of pre-eclampsia on incidence and performance of first-trimester screening.
    Khan N; Andrade W; De Castro H; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Jan; 55(1):50-57. PubMed ID: 31503372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
    Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
    Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of screening performance of first-trimester competing-risks prediction model for small-for-gestational age in Asian population.
    Nguyen-Hoang L; Papastefanou I; Sahota DS; Pooh RK; Zheng M; Chaiyasit N; Tokunaka M; Shaw SW; Seshadri S; Choolani M; Yapan P; Sim WS; Poon LC;
    Ultrasound Obstet Gynecol; 2024 Mar; 63(3):331-341. PubMed ID: 37552550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE.
    Tan MY; Poon LC; Rolnik DL; Syngelaki A; de Paco Matallana C; Akolekar R; Cicero S; Janga D; Singh M; Molina FS; Persico N; Jani JC; Plasencia W; Greco E; Papaioannou G; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Jul; 52(1):52-59. PubMed ID: 29704277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASPRE trial: incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm.
    Poon LC; Rolnik DL; Tan MY; Delgado JL; Tsokaki T; Akolekar R; Singh M; Andrade W; Efeturk T; Jani JC; Plasencia W; Papaioannou G; Blazquez AR; Carbone IF; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):738-742. PubMed ID: 29380918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of first-trimester screening strategy for preterm pre-eclampsia and its clinical applicability in China.
    Hu J; Gao J; Liu J; Meng H; Hao N; Song Y; Ma L; Luo W; Sun J; Gao W; Meng W; Sun Y
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):529-539. PubMed ID: 33817865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations.
    O'Gorman N; Wright D; Poon LC; Rolnik DL; Syngelaki A; de Alvarado M; Carbone IF; Dutemeyer V; Fiolna M; Frick A; Karagiotis N; Mastrodima S; de Paco Matallana C; Papaioannou G; Pazos A; Plasencia W; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):756-760. PubMed ID: 28295782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population.
    Chaemsaithong P; Pooh RK; Zheng M; Ma R; Chaiyasit N; Tokunaka M; Shaw SW; Seshadri S; Choolani M; Wataganara T; Yeo GSH; Wright A; Leung WC; Sekizawa A; Hu Y; Naruse K; Saito S; Sahota D; Leung TY; Poon LC
    Am J Obstet Gynecol; 2019 Dec; 221(6):650.e1-650.e16. PubMed ID: 31589866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes.
    Lai J; Syngelaki A; Nicolaides KH; von Dadelszen P; Magee LA
    Am J Obstet Gynecol; 2021 May; 224(5):518.e1-518.e11. PubMed ID: 33166504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STATIN trial: predictive performance of competing-risks model in screening for pre-eclampsia at 35-37 weeks' gestation.
    Döbert M; Wright A; Varouxaki AN; Mu AC; Syngelaki A; Rehal A; Delgado JL; Akolekar R; Muscettola G; Janga D; Singh M; Martin-Alonso R; Dütemeyer V; De Alvarado M; Atanasova V; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2022 Jan; 59(1):69-75. PubMed ID: 34580947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylated fibronectin improves first-trimester prediction of pre-eclampsia.
    Moungmaithong S; Wang X; Lau CSL; Tse AWT; Lee NMW; Leung HHY; Poon LC; Sahota DS
    Ultrasound Obstet Gynecol; 2023 Oct; 62(4):512-521. PubMed ID: 37616523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competing-risks model for pre-eclampsia and adverse pregnancy outcomes.
    Syngelaki A; Magee LA; von Dadelszen P; Akolekar R; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2022 Sep; 60(3):367-372. PubMed ID: 35866878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competing-risks model in screening for pre-eclampsia in twin pregnancy according to maternal factors and biomarkers at 11-13 weeks' gestation.
    Francisco C; Wright D; Benkő Z; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Nov; 50(5):589-595. PubMed ID: 28556556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis.
    Shen L; Martinez-Portilla RJ; Rolnik DL; Poon LC
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):546-552. PubMed ID: 33998099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of preterm pre-eclampsia according to NICE and ACOG criteria: descriptive study of 597 492 Danish births from 2008 to 2017.
    Rode L; Ekelund CK; Riishede I; Rasmussen S; Lidegaard Ø; Tabor A
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):561-567. PubMed ID: 34021947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revised competing-risks model in screening for pre-eclampsia in twin pregnancy by maternal characteristics and medical history.
    Benkő Z; Chaveeva P; de Paco Matallana C; Zingler E; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Nov; 54(5):617-624. PubMed ID: 31364214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnosis of pre-eclampsia using two revised classifications in the Finnish Pre-eclampsia Consortium (FINNPEC) cohort.
    Kallela J; Jääskeläinen T; Kortelainen E; Heinonen S; Kajantie E; Kere J; Kivinen K; Pouta A; Laivuori H
    BMC Pregnancy Childbirth; 2016 Aug; 16():221. PubMed ID: 27520381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-stage approach for prediction of small-for-gestational-age neonate and adverse perinatal outcome by routine ultrasound examination at 35-37 weeks' gestation.
    Akolekar R; Panaitescu AM; Ciobanu A; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):484-491. PubMed ID: 31271475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of competing-risks model in screening for pre-eclampsia in twin pregnancy by maternal factors.
    Benkő Z; Chaveeva P; de Paco Matallana C; Zingler E; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 May; 53(5):649-654. PubMed ID: 30887621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation.
    O'Gorman N; Wright D; Poon LC; Rolnik DL; Syngelaki A; Wright A; Akolekar R; Cicero S; Janga D; Jani J; Molina FS; de Paco Matallana C; Papantoniou N; Persico N; Plasencia W; Singh M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):751-755. PubMed ID: 28067011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.